Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (Q47734769)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in February 1998

Language	Label	Description	Also known as
English	Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?	scientific article published in February 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

0 references

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

0 references

Thierry Poynard

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

author name string

Mathurin P

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Rixe O

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Carbonell N

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Bernard B

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Cluzel P

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Bellin MF

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Khayat D

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Opolon P

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

111-126

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Surgical resection and survival in Western patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Meta-analyses of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Methods for combining randomized clinical trials: strengths and limitations.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Natural history of hepatocellular carcinoma in Spain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection,

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

21 January 2018

Identifiers

10.1046/J.1365-2036.1998.00286.X

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9692685

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47734769&oldid=1208350602"